Abstract: An adjustable multipurpose rack which can be used for the storage of pipe and other elongated goods. The adjustable multipurpose rack has movable stanchions to accommodate a changing supply and profiles of elongated goods. The adjustable multipurpose rack comprises at least one base and a plurality of stanchions. The plurality of stanchions comprises of at least one movable stanchion defining at least one compartment. The movable stanchion can be driven by an actuation mechanism or by hand should the actuation mechanism fail.

Abstract: The present invention provides a system and method for controlling an asphalt repair apparatus. An additional aspect of the present invention is to provide a system that may position a heater repair element adjacent a targeted asphalt surface, acquire and analyze surface and heater sensing data, and control heater output to prepare the targeted asphalt surface for repair. Further, the system may be configured to control an asphalt repair apparatus to satisfy user-defined asphalt repair requirements.

Abstract: The present invention provides a system and method for controlling an asphalt repair apparatus. An additional aspect of the present invention is to provide a system that may position a heater repair element adjacent a targeted asphalt surface, acquire and analyze surface and heater sensing data, and control heater output to prepare the targeted asphalt surface for repair. Further, the system may be configured to control an asphalt repair apparatus to satisfy user-defined asphalt repair requirements.

Abstract: The present invention provides a system and method for controlling an asphalt repair apparatus. An additional aspect of the present invention is to provide a system that may position a heater repair element adjacent a targeted asphalt surface, acquire and analyze surface and heater sensing data, and control heater output to prepare the targeted asphalt surface for repair. Further, the system may be configured to control an asphalt repair apparatus to satisfy user-defined asphalt repair requirements.

Abstract: The present invention provides a system and method for controlling an asphalt repair apparatus. An additional aspect of the present invention is to provide a system that may position a heater repair element adjacent a targeted asphalt surface, acquire and analyze surface and heater sensing data, and control heater output to prepare the targeted asphalt surface for repair. Further, the system may be configured to control an asphalt repair apparatus to satisfy user-defined asphalt repair requirements.

Abstract: The present invention relates to a protein composition suitable for inducing an immune response in a vertebrate comprising 2 to 10 protein variants of a single antigen, which is the APICAL MEMBRANE ANTIGEN 1 (PfAMA1 OR AMA1) of a Plasmodium species. The antigen comprises a plurality of variable amino acid positions, wherein the amino acid sequences of said protein variants, in combination, represent both the frequency of occurrence of each amino acid at said variable amino acid positions and the linkage between the variable amino acid positions, and wherein said frequency of occurrence is at least between 10% to 20% such as 10%, 11%, 12%, 13%, . . . , 20% in the single antigen, and wherein at least 75% of the linkages between the variable amino acid position is presented by the combination of protein variants.

Abstract: The present invention relates to a protein composition suitable for inducing an immune response in a vertebrate comprising 2 to 10 protein variants of a single antigen, which is the APICAL MEMBRANE ANTIGEN 1 (PfAMA1 OR AMA1) of a Plasmodium species. The antigen comprises a plurality of variable amino acid positions, wherein the amino acid sequences of said protein variants, in combination, represent both the frequency of occurrence of each amino acid at said variable amino acid positions and the linkage between the variable amino acid positions, and wherein said frequency of occurrence is at least between 10% to 20% such as 10%, 11%, 12%, 13%, . . . , 20% in the single antigen, and wherein at least 75% of the linkages between the variable amino acid position is presented by the combination of protein variants.

Abstract: A manual (1) comprising a binder (6) and pages (3) releasably retained in the binder (6) comprises apparatus (2) for identifying an opened page (3) and for transmitting the identity of the page (3) to a computer (4). The apparatus (2) comprises a carrier member (15) which carries a plurality of photo sensors (16) for reading a binary identity code (17) along an edge of each page (3) for identifying the page. A plurality of input keys (37) on the carrier member (15) carry identifying symbols (40) which correspond to identifying symbols (41) provided on the pages (3) adjacent passages of text for facilitating inputting of select signals for operating the computer (4) to display additional data on a visual display unit (5) relating to the passage identified by the corresponding identifying symbol.

Abstract: Provided is a method of treating or ameliorating or preventing glaucoma, decreasing intraocular pressure or improving or amemliorting ocular accommodation in an animal, including a human comprising administering an intraocular pressure decreasing or accommodation improving amount of a compound of the formula I:

Abstract: A light guide (1) formed from an unclad flexible polyurethane fibre produces significant side scattering (2) over distances of up to several metres. The polyurethane fibre is in the form of a solid fibre or a tube and may comprise light scattering particles. The polyurethane fibre may comprise a transparent flexible polyurethane UV resistant outer cladding. Embodiments include illuminated shoe laces, a power cord safety indicator, an illuminated dental suction tube and a dental curing tip.

Abstract: The invention relates to a light emitting device consisting of one or more light sources coupled to a light guide containing diffuser particles having a refractive index close to the refractive index of the core of the light guide. The diffuser particles cause a scattering of the light emitted from the light sources so that light emitted from the light emitting device has colour variation imperceptible to the human eye and small and gradual variations in intensity.

Abstract: The invention relates to side-scattering light guides that generally comprise a core of transparent optically homogenous material seeded with diffuser particles. The light guide also comprises an optically transmitting sheath, having a lowerrefractive index than the core, surrounding and in contact with the sides of the core to prevent any light being transmitted along the core from escaping through the core's sides. In general, the diffuser particles impart only a small deviation to light rays incident upon them, and are distributed to scatter light being transmitted along the core so that at least some of the scattered light exits the sides of the core. A diffusing jacket is arranged to intercept scattered light exiting the sides of the core.

Abstract: An automated dermatological examination system captures an image including a lesion. The image is divided into lesion and non-lesion areas, and the lesion area is analysed to quantify features for use in diagnosis of the lesion. Features of lesion colour are extracted (step 502) and the shape of the lesion is analysed (step 504). Features of lesion texture and symmetry are derived (step 506) as are measures of categorical symmetry within the lesion (step 508).

Abstract: A scanner including a glass plate under which a scanning head moves on rails forms part of an integrated automated gel excision and sample processing apparatus which includes a moveable machine head mounted for movement in X and Y directions along an X axis and Y axis. A cutting head is mounted for movement up and down a vertical Z Axis. A series of four crosses (22) known as “fiducials” are defined at each corner of the glass plate on the underside so that they superpose onto the scanned image of a gel on the plate. The scanned image thus includes reference points for the spots in the array. A grey scale card (24) is scanned along with the image of the gel whose luminance is known and has known reflection densities that can be applied to each colour in the image, red green blue etc and used to work out the intensity of each spot in the array so that absolute intensity values can be compared from image to image and scanner to scanner.

Abstract: Provided is a method of treating or ameliorating or preventing glaucoma, decreasing intraocular pressure or improving or amemliorting ocular accommodation in an animal, including a human comprising administering an intraocular pressure decreasing or accommodation improving amount of a compound of the formula I: 1

Abstract: The invention disclosed is a circuit for regulating optical power levels. Electrooptic attenuators are used to control optical output intensity by means of feedback loops from the outputs of the attenuators to the electrodes of the attenuators which determine the amount of light going to the outputs. The attenuators may be used in combination with an optical switch array in a wavelength division multiplexing system.

Abstract: The present invention provides anti-neoplastic topoisomerase I inhibitors of the formula: ##STR1## wherein Ar is (C.sub.6 -C.sub. 12)aryl or (6- to 12-membered) heteroaryl comprising 1-3 N, S or non-peroxide O, wherein N is unsubstituted or is substituted with (C.sub.1 -C.sub.4)alkyl; X is H, CN, CHO, OH, acetyl, CF.sub.3, OCH.sub.3, NO.sub.2 or NH.sub.2 ; each Y is individually H, (C.sub.1 -C.sub.4)alkyl or aralkyl; Y' is H or (C.sub.1 -C.sub.4)alkyl; n is 0 or 1; or a pharmaceutically acceptable salt therein.

Abstract: The present invention provides anti-neoplastic topoisomerase I inhibitors of the formula: ##STR1## wherein Ar is (C.sub.6 -C.sub.12)aryl or (6- to 12-membered) heteroaryl comprising 1-3 N, S or non-peroxide O, wherein N is unsubstituted or is substituted with (C.sub.1 -C.sub.4)alkyl; X is H, CN, CHO, OH, acetyl, CF.sub.3, OCH.sub.3, NO.sub.2 or NH.sub.2 ; each Y is individually H, (C.sub.1 -C.sub.4)alkyl or aralkyl; Y' is H or (C.sub.1 -C.sub.4)alkyl; n is 0 or 1; or a pharmaceutically acceptable salt therein.